Laura oversees the Harvard Program in Therapeutic Science and co-directs programs for research, education and business creation at Harvard Medical School. As a co-founder of the Laboratory of Systems Pharmacology, she enables grant-funded research programs which combine computational modeling and precise measurement to understand drug action in humans. She is also launching the Blavatnik Life Lab at Harvard Medical School, a biotech incubator embedded in the Harvard campus focused on improving therapeutic development. Prior to joining HMS, Maliszewski worked in the UK Foreign and Commonwealth Office, developing a broad portfolio of research collaborations in regenerative medicine, health economics and stratified medicine. She is responsible for the strategic alliance of the UK Stem Cell Bank with the Massachusetts Human Stem Cell Bank and Registry, and contributed to the development of the UK Catapult Centers for technology development. Laura holds a BS in Biotechnology from the University of Delaware and a PhD in Virology from the Harvard Division of Medical Sciences. She completed her doctoral studies in the lab of Judy Lieberman at the Immune Disease Institute and Harvard Medical School studying the perturbation of microRNAs during HIV infection of primary lymphocytes.